(EMAILWIRE.COM, July 19, 2019 ) According to the new market research report “Cell Signaling Market by Type (Endocrine, Paracrine), Pathway (Akt, AMPK, Hedgehog, Notch), Product (Consumables, Instruments), Technology (Flow Cytometry, ELISA, Mass Spectrometry) & Application (Research, Cancer, Immunology) — Global Forecast”, published by MarketsandMarkets™.

Growth in the Cell Signaling Market is driven by the rising incidence of chronic diseases, availability of funding for cell-based research, technological advancements in cell-based research instruments, and the growth of the life science and biopharmaceutical industries.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=80206120

This report segments the Cell Signaling Market on the basis of product, pathway, signaling type, technology, application, and region.

Based on the product, the market is segmented into consumables and instruments. The cell signaling consumables segment is estimated to account for the largest share of the Cell Signaling Market in 2017. The increasing number of cell signaling research activities and the rising incidence of chronic diseases are some of the major factors contributing to the segments large market share.

Browse and in-depth TOC on “Cell Signaling Market”
157 — Tables
76 — Figures
212 — Pages

Based on the signaling type, the market is segmented into paracrine, endocrine, autocrine, juxtacrine, and other signaling types (intracrine and neuronal signaling). The endocrine segment is estimated to account for the largest share of the Cell Signaling Market.

On the basis of technology, the Cell Signaling Market is segmented into enzyme-linked immunosorbent assay (ELISA), immunohistochemistry (IHC), microscopy, flow cytometry, western blotting, mass spectrometry, and other technologies (immunofluorescence and immunoprecipitation). The microscopy segment is estimated to account for the largest share.


Read Press-Release on “Cell Signaling Market”: https://www.marketsandmarkets.com/PressReleases/cell-signaling.asp

On the basis of region, the market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). North America is estimated to account for the largest share of the Cell Signaling. Growth in this regional segment is driven by the growth in geriatric population, rising incidence of chronic diseases, and improved life science research infrastructure in the region.

The key players in the Cell Signaling Market include Merck KGaA (Germany), Thermo Fisher Scientific Inc. (U.S.), Becton, Dickinson and Company (U.S.), Beckman Coulter, Inc. (U.S.) (a subsidiary of Danaher Corporation), Bio-Rad Laboratories, Inc. (U.S.), PerkinElmer Inc. (U.S.), QIAGEN N.V. (Netherlands), Cell Signaling Technology, Inc. (U.S.), Promega Corporation (U.S.), Bio-Techne Corporation (U.S.), Abcam plc (U.K.), Miltenyi Biotec (Germany)